Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Drug Resistance

  Free Subscription


21.10.2019

3 Antimicrob Agents Chemother
5 Clin Infect Dis
1 Crit Care Med
1 Int J Antimicrob Agents
5 J Antimicrob Chemother
3 J Med Microbiol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. CEBALLOS S, Kim C, Qian Y, Mobashery S, et al
    Susceptibility of methicillin-resistant Staphylococcus aureus to five quinazolinone antibacterials.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01344.
    PubMed     Text format     Abstract available

  2. RAMIREZ-ZAVALA B, Manz H, Englert F, Rogers PD, et al
    A hyperactive form of the zinc cluster transcription factor Stb5 causes YOR1 overexpression and beauvericin resistance in Candida albicans.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01655.
    PubMed     Text format     Abstract available

  3. GUITOR AK, Raphenya AR, Klunk J, Kuch M, et al
    Capturing the Resistome: A targeted capture method to reveal antibiotic resistance determinants in metagenomes.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01324.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  4. KIRCHHELLE C, Dyson ZA, Dougan G
    A Biohistorical Perspective of Typhoid and Antimicrobial Resistance.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  5. RAYMOND S, Nicot F, Pallier C, Bellecave P, et al
    Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen.
    Clin Infect Dis. 2017 Dec 13. pii: 4736156. doi: 10.1093/cid/cix1070.
    PubMed     Text format     Abstract available

  6. YEGANEH N, Kerin T, Ank B, Watts H, et al
    HIV antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study.
    Clin Infect Dis. 2017 Dec 19. pii: 4762480. doi: 10.1093/cid/cix1104.
    PubMed     Text format     Abstract available

  7. TAIWO BO, Marconi VC, Berzins B, Moser CB, et al
    Dolutegravir plus lamivudine maintain HIV-1 suppression through week 48 in a pilot randomized trial.
    Clin Infect Dis. 2017 Dec 26. pii: 4775007. doi: 10.1093/cid/cix1131.
    PubMed     Text format     Abstract available

  8. NACHEGA JB, Sam-Agudu NA, Mofenson LM, Schechter M, et al
    Achieving Viral Suppression in 90% of People Living with HIV on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities.
    Clin Infect Dis. 2018 Jan 8. pii: 4793055. doi: 10.1093.
    PubMed     Text format    


    Crit Care Med

  9. LU C, Liu Q, Yuan H, Wang L, et al
    Implementation of the Smart Use of Antibiotics Program to Reduce Unnecessary Antibiotic Use in a Neonatal ICU: A Prospective Interrupted Time-Series Study in a Developing Country.
    Crit Care Med. 2019;47:e1-e7.
    PubMed     Text format     Abstract available


    Int J Antimicrob Agents

  10. CHEN CH, Huang CL, He MS, Huang FC, et al
    Characterization of the beta-lactam-resistant enzyme in Acanthamoeba castellanii.
    Int J Antimicrob Agents. 2019 Oct 14. pii: S0924-8579(19)30278.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  11. KARLOWSKY JA, Adam HJ, Golden AR, Baxter MR, et al
    Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available

  12. ZHANEL GG, Adam HJ
    Introduction to the SAVE study (2011-15): Streptococcus pneumoniae serotyping and antimicrobial susceptibility: Assessment for Vaccine Efficacy in Canada after the introduction of PCV-13.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available

  13. ADAM HJ, Golden AR, Karlowsky JA, Baxter MR, et al
    Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available

  14. GOLDEN AR, Adam HJ, Karlowsky JA, Baxter M, et al
    Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available

  15. AUTMIZGUINE J, Smith PB, Prather K, Bendel C, et al
    Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.
    J Antimicrob Chemother. 2018 Sep 20. pii: 5104445. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Microbiol

  16. BETTS JW, Hornsey M, Higgins PG, Lucassen K, et al
    Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    J Med Microbiol. 2019;68:1552-1559.
    PubMed     Text format     Abstract available

  17. MARTINI H, Soetens O, Litt D, Fry NK, et al
    Diphtheria in Belgium: 2010-2017.
    J Med Microbiol. 2019;68:1517-1525.
    PubMed     Text format     Abstract available

  18. O LUIZ FB, Alves KB, Barros RR
    Prevalence and long-term persistence of beta-haemolytic streptococci throat carriage among children and young adults.
    J Med Microbiol. 2019 Aug 16. doi: 10.1099/jmm.0.001054.
    PubMed     Text format     Abstract available


    PLoS One

  19. SOTOMAYOR MA, Reyes JK, Restrepo L, Dominguez-Borbor C, et al
    Efficacy assessment of commercially available natural products and antibiotics, commonly used for mitigation of pathogenic Vibrio outbreaks in Ecuadorian Penaeus (Litopenaeus) vannamei hatcheries.
    PLoS One. 2019;14:e0210478.
    PubMed     Text format     Abstract available

  20. UPTON EC, Maciunas LJ, Loll PJ
    Vancomycin does not affect the enzymatic activities of purified VanSA.
    PLoS One. 2019;14:e0210627.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: